Literature DB >> 25498504

Neuronal pentraxin 1 expression is regulated by hypoxia inducible factor-1α.

Mahendran Botlagunta1.   

Abstract

Neuronal pentraxins (NPs) are belong to sub family of long pentraxin proteins consist of neuronal pentraxin 1 (NP1), neuronal pentraxin 2 (NP2), and neuronal pentraxin receptor (NPR). Enhanced expression of NP1 in hypoxic conditions has shown to induce cell death in neuronal cells, however, the underlying mechanism of NP1 regulation by hypoxia remains elusive. To demonstrate that, we have cloned human NP1 gene promoter upstream of the luciferase gene and the activity of NP1 promoter was studied using HEK cell lines. Within the promoter region of the human NP1 gene, we identified six putative hypoxia inducible factor (HIF) responsive elements. By luciferase reporter assays we determined that the hypoxia inducible factor responsive element is located between -332 to -215 positions relative to the translation start site are essential for transcriptional activation of NP1 under hypoxic conditions. To further confirm the activity is solely due to hypoxia, we transiently transfected green fluorescent protein (EGFP) under transcriptional control of five copies of a hypoxia response element (HRE). The intensity of GFP was recorded at normal and hypoxic conditions. Taken together, our results demonstrate that NP1 gene is a target of as a hypoxia-inducible factor and it regulate NP1 expression by binding to hypoxia responsive elements (HREs) in its promoter region.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Green fluorescent protein (EGFP); Hypoxia response element (HRE); Neuronal pentraxin 1 (NP1)

Mesh:

Substances:

Year:  2014        PMID: 25498504     DOI: 10.1016/j.bbrc.2014.12.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Neuroprotective mechanism of HIF-1α overexpression in the early stage of acute cerebral infarction in rats.

Authors:  Yuhua Sun; Weiya He; Lijiao Geng
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.